← Eichor
Study identifier: NCT06608849 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19

Condition: Pulmonary Complications · Cardiovascular Complications · Renal Complications  ·  Sponsor: Hellenic Institute for the Study of Sepsis

PhaseN/A
Planned participants345
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

More than 660 million cases of COVID-19 have been reported worldwide, with 183 million cases in the EU alone. In several people, after recovery, the effects of the first waves of COVID-19 persisted beyond the acute phase and increased the risk of chronic multiorgan symptoms and disease. Up to 70% of people affected by COVID-19 showed reduced organ function even four months or more after COVID-19 diagnosis. Such a functional decline is associated with an increased risk of the development of non-communicable diseases (NCDs). Thus, there is an essential need for a better knowledge, tools, clinical guidelines and recommendations that it will make it possible to reduce this overrepresentation of NCDs as a consequence of the post-acute phase (PAP) of COVID-19. The overall concept underpinning "POINT" is to i) build detailed knowledge on the link between the PAP of COVID-19 caused by previous, current, and future SARS-CoV-2 variants in vaccinated and unvaccinated people, and NCDs, ii) identify robust biomarkers and build predictive tools that help early identification and management of risk of NCDs, and iii) develop guidelines and recommendations for all parts of the healthcare value chain, allowing best prevention and care acknowledging vulnerability. The investigators will focus on the NCDs affecting pulmonary, cardiovascular and renal systems.

This description comes directly from the study's public registry record.

Talk to the study team

Prof. Evangelos Giamarellos-Bourboulis  ·  00302105831994  ·  egiamarel@med.uoa.gr

Always discuss trial participation with your own doctor first.

Locations (6)

10th Department of Pulmonary Medicine, Sotiria Athens Hospital of Chest DiseasesAthens, GreeceRecruiting
4th Department of Internal Medicine, ATTIKON University General HospitalAthens, GreeceRecruiting
Obstructive Diseases Clinic, Sotiria Athens Hospital of Chest DiseasesAthens, GreeceRecruiting
Out-patient department of Infectious Diseases, Sotiria Athens Hospital of Chest DiseasesAthens, GreeceRecruiting
1st Department of Internal Medicine, Thriasio General Hospital of ElefsinaElefsina, GreeceRecruiting
2nd Department of Internal Medicine, Thriasio General Hospital of ElefsinaElefsina, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06608849